T1	Participants 37 76	acromegalic patients with macroadenomas
T2	Participants 273 328	newly diagnosed acromegalic patients with macroadenomas
T3	Participants 848 860	108 patients
T4	Participants 1655 1705	patients with GH-secreting pituitary macroadenomas
